The Burdenko Military Hospital in Moscow is completing clinical trials with a coronavirus vaccine this Monday, a preliminary move towards its potential widespread use.
“The clinical trials with the Russian coronavirus vaccine, which were developed in cooperation between the Russian Ministry of Defense and the Center for Epidemiology and Microbiology Gamaleya, will be completed at Burdenko Hospital,” said the director of the No. 48 Scientific Research Center of the Nuclear Forces , biological and chemical protection, Lieutenant Colonel Sergei Borisevich.
Upon completion of the tests, the 20 volunteers from the second and last groups who participated in the trials will be released from the hospital, Borisevich said in an interview with Krasnaya Zvezda, the official newspaper of the Russian Armed Forces, published by Sputnik News.
Borisevich emphasized that the scientists still have a “large amount” of analytical work ahead of them and that they have to prepare final reports, present the results and register the vaccine.
A dozen Russian centers are currently developing vaccines against COVID-19, the most advanced of which are the Gamaleya Center for Epidemiology and Microbiology, the Vector Center and the Vaccine Institute of the Federal Office of Medicine and Biology.